Study of Taxoprexin Injection vs. Dacarbazine in Patients With Metastatic Malignant Melanoma.
Phase of Trial: Phase III
Latest Information Update: 16 Mar 2011
At a glance
- Drugs Dacarbazine; DHA-paclitaxel
- Indications Malignant melanoma
- Focus Registrational; Therapeutic Use
- 16 Mar 2011 Actual end date (Oct 2007) added as reported by ClinicalTrials.gov.
- 16 Mar 2011 Status changed from discontinued to completed as reported by ClinicalTrials.gov.
- 22 Aug 2007 Status change from recruiting to in progress.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History